|
SLC17A5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.91310000000301E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
3.1131763833514E-12 |
| Stage1-vs-Stage2 |
7.309700E-02 |
| Stage1-vs-Stage3 |
8.965800E-01 |
| Stage1-vs-Stage4 |
9.146400E-02 |
| Stage2-vs-Stage3 |
9.437700E-02 |
| Stage2-vs-Stage4 |
8.263900E-03 |
| Stage3-vs-Stage4 |
7.468100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.51729999997574E-06 |
| Normal-vs-Asian |
2.38500330596025E-11 |
| Caucasian-vs-AfricanAmerican |
3.188200E-01 |
| Caucasian-vs-Asian |
1.390790E-01 |
| AfricanAmerican-vs-Asian |
9.240800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.598800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.28830279777503E-11 |
| Normal-vs-Age(81-100Yrs) |
3.423700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.410600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.742620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.129400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.306200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.146400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.404200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.959200E-01 |
| Classical-VS-Follicular |
8.33589863802331E-11 |
| Classical-VS-Other |
3.949200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.12600000001795E-06 |
| Tall-VS-Other |
5.527800E-01 |
| Tall-VS-Normal |
5.51447776331315E-13 |
| Follicular-VS-Other |
1.870640E-01 |
| Follicular-VS-Normal |
3.423400E-04 |
| Other-VS-Normal |
8.305900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62492241884138E-12 |
| Normal-vs-N1 |
6.9673999902875E-10 |
| N0-vs-N1 |
1.770400E-01 |
|
|
